Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 12,863

Document Document Title
WO/2011/037975A2
The present invention describes the method of making anionic ether sulfate surfactants by alkoxylation of a GA using PO and/or EO followed by a sulfation reaction. The GA of the present invention is made by a facile and inexpensive metho...  
WO/2010/135350A3
Disclosed herein are methods and compounds useful in preparing N-(3,4-dimethyl-5-isoxazolyl)-2-(4-(2-butyl-4-oxo-l,3-diazos piro[4.4]non-l-en-3yl)methyl-2-ethoxymethylphenyl)phenylsulf onamide.  
WO/2011/000461A3
The invention relates to a continuous method for N-acylating amino group-carrying organic acids by reacting at least one carboxylic acid of formula (I) R1-COOH (I), wherein R1 represents hydrogen or an optionally substituted hydrocarbon ...  
WO/2011/037613A1
The present invention relates to salts of 2-(2-((4-(((4-chlorophenyl)(phenyl)-carbamoyloxy)methyl)cycl ohexyl)methoxy)acetamido)ethanesulfonic acid (Compound 1) and crystalline forms, solvates and hydrates thereof. The present invention ...  
WO/2011/014553A3
Produce a sulfo-chlorinated hydrocarbon using liquid sulfur dioxide, a chlorinating agent such as chlorine or sulfuryl chloride, and a metal complex catalyst, the catalyst being represented as LnM where L is at least one of an amine, pho...  
WO/2011/033194A1
The invention relates to a method for synthesizing ivabradine of formula (I) and to the addition salts thereof with a pharmaceutically acceptable acid.  
WO/2011/030921A1
Disclosed are a biphenyltetrasulfonic acid compound represented by formula (1), and a polymer which contains a structural unit originating in said biphenyltetrasulfonic acid compound. In formula (1), R1 represents a hydrogen atom, a cati...  
WO/2010/099532A8
A method for the purification of 5-sulfoisophthalic acid wherein via the application of an acetic acid wash while said crude cake of 5-sulfoisophthalic acid is filtered.  
WO/2011/030737A1
Disclosed is a radiation-sensitive composition capable of forming a chemically amplified positive resist film, which is effectively sensitive to (extreme) far ultraviolet rays such as KrF excimer lasers, ArF excimer lasers, and EUV, X-ra...  
WO/2010/063403A3
The invention relates to the compounds suitable for radiolabeling with a chelator free radioisotope and radiolabeled compounds of the general Formula (I). Said compounds are ornithine or lysine derivatives.  
WO/2011/024988A1
Disclosed is a novel ionic liquid which can be produced at low cost, is safe for the environment, and has a low viscosity and a low melting point. Specifically disclosed is an ionic liquid represented by general formula [1] (wherein R1 t...  
WO/2011/025267A2
The present invention relates to metformin methanesulfonate, to a method for preparing same, to a pharmaceutical composition comprising same, and to a combined formulation comprising same. The metformin methanesulfonate of the present in...  
WO/2011/025269A2
The present invention relates to metformin taurate, to a method for preparing same, to a pharmaceutical composition comprising same, and to a combined formulation comprising same. The metformin taurate of the present invention has superi...  
WO/2011/022429A2
The present invention relates to a process for the preparation of alkyl esters of (S) 2-amino-5-cyclopropyl-4,4-difluoropentanoic acid, which are intermediates useful in the synthesis of (S)-N-(1-cyanocyclopropyl)-5-cyclopropyl-4,4-diflu...  
WO/2011/017800A1
The invention relates to methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid (1,3PDS) in a subject, preferably a human subject. The invention encompasses compounds that will yield or generate 1,3PDS, either in ...  
WO/2010/123599A9
This disclosure relates to compositions and methods including for the inhibition, prevention, and/or treatment of microbial infections, including infections from such pathogens as Staphylococcus aureus.  
WO/2011/016523A1
Disclosed are: a process for producing a bis-quaternary ammonium salt with high efficiency; and a novel synthetic intermediate for the process. Specifically disclosed are: a process for producing a bis-quaternary ammonium salt represente...  
WO/2010/003567A3
The present invention provides new compounds with CF3O end groups, provides for their use as surface-active substances, and provides preparation processes for these compounds.  
WO/2011/013615A1
Provided is a fluorine-containing compound represented by general formula (1), which exhibits an excellent surface tension lowering effect, though the fluorine-containing compound is a low-environment-load type, fluorine-containing mater...  
WO/2011/013834A1
Disclosed is a method for producing a biaryl compound represented by formula (2): Ar-Ar, wherein Ar represents an aromatic group which can have a substituent, comprising carrying out the coupling reaction of a compound represented by for...  
WO/2011/013635A1
Disclosed is a protected 2-fluoropropylamine (general formula [1]) having a leaving group at the 3-position or a protected N-alkyl-2-fluoropropylamine (general formula [2]) having a leaving group at the 3-position, which can be highly ef...  
WO/2011/009947A1
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt, a stereoisomer or a mixture in all proportions of stereoisomers thereof, in particular a mixture of enantiomers, such as a racemic mixture,...  
WO/2010/099532A3
A method for the purification of 5-sulfoisophthalic acid wherein via the application of an acetic acid wash while said crude cake of 5-sulfoisophthalic acid is filtered.  
WO/2011/010524A1
Provided is a process by which high-purity alkoxybenzenesulfonyl chlorides can be produced industrially, easily and efficiently. A process for the production of alkoxybenzenesulfonyl chlorides represented by general formula (2) [wherein ...  
WO/2011/009541A1
The present invention relates to the preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxy phenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxy p...  
WO/2011/010997A1
Sulfo-estolides and methods of making them are described. Also described are phase-stable compositions formed from mixtures of different salts of sulfo-estolides, particularly mixtures of sodium and potassium salts of sulfo-estolides, an...  
WO/2010/123599A3
This disclosure relates to compositions and methods including for the inhibition, prevention, and/or treatment of microbial infections, including infections from such pathogens as Staphylococcus aureus.  
WO/2011/006621A1
This invention relates to novel cyclo alkyl compounds suitable for labeling by 18F, methods of preparing such a compound, compositions comprising such compounds, kits comprising such compounds or compositions and uses of such compounds, ...  
WO/2011/008570A2
Provided are new anionic surfactants and methods of their preparation and use. The surfactants are compounds of the formula I: wherein R, R1, R2, R3, R4, R5, and R6 are as defined herein.  
WO/2010/149262A1
The present invention relates to novel compounds having fluoridated terminal groups, to the use thereof as surfactant substances, and to a method for producing said compounds.  
WO/2010/150205A1
Novel compounds are continually sought after to treat and prevent diseases and disorders. The invention relates to 1-(sulfonyl)-N-phenylpyrrolidine-2-carboxamides which are useful for being biologically and pharmacologically screened, an...  
WO/2010/148177A2
Embodiments of the present disclosure provide for chloride channel or transporter compounds or compositions (inhibitors or agents), methods of synthesizing these compounds or compositions, methods of treatment using these compounds or co...  
WO/2010/147228A1
A pattern forming method, including: (i) forming a film from a chemical amplification resist composition; (ii) exposing the film, so as to form an exposed film; and (iii) developing the exposed film by using a developer containing an org...  
WO/2009/124371A9
The present invention relates to compounds derived from taurine with non-steroidal anti inflammatory activity. In a first embodiment, the present invention relates to compounds derived from taurine, in which taurine is bound directly by ...  
WO/2010/135350A2
Disclosed herein are methods and compounds useful in preparing N-(3,4-dimethyl-5-isoxazolyl)-2-(4-(2-butyl-4-oxo-l,3-diazos piro[4.4]non-l-en-3yl)methyl-2-ethoxymethylphenyl)phenylsulf onamide.  
WO/2010/130378A1
Compounds of the general formula (I) a process for their preparation and their use for dyeing and/or printing organic substrates.  
WO/2010/130379A1
Compounds of the general formula (I) a process for their preparation and their use for dyeing and/or printing organic substrates.  
WO/2010/121719A1
This invention relates to novel compounds suitable as precursors for the preparation of certain F-18 labeled positron emission tomography (PET) tracers. Furthermore, the invention relates to the preparation of such precursor molecules an...  
WO/2010/124151A1
Embodiments of the present invention disclose an agricultural composition that is a field ready spray or a tank mix that includes at least one nitrogen containing isethionic acid salt, at least one agriculturally active ingredient, and a...  
WO/2010/123060A1
Provided is a fatty acid alkyl ester sulfonate metal salt mixture comprising: (a) a fatty acid alkyl ester sulfonate metal salt for which the heat-absorption peak area between 50°C and 130°C is less than 50% of the total absorption pea...  
WO/2010/118889A1
Process for manufacturing 1-amino-1,3,3, 5, 5-pentamethylcyclohexane mesylate comprising step (i): (i) reacting 1-amino-1, 3, 3, 5, 5-pentamethylcyclohexane with methane sulfonic acid in a solvent or a mixture of two or more solvents sel...  
WO/2010/030781A3
Prodrug compounds which metabolize into 5-ASA or analogs thereof, and taurine or analogs thereof, in the colon site are disclosed. Pharmaceutical compositions including the compounds, and methods of treatment using the compounds, are als...  
WO/2010/116736A1
Disclosed is a method for producing an alkanolamine salt of an α-sulfo fatty acid alkyl ester, comprising: a step of sulfonating a fatty acid alkyl ester to obtain a sulfonated compound; a step of reacting an alcohol and hydrogen peroxi...  
WO/2010/114144A1
The present invention provides a novel propylene oxide and a method for producing the same as well as a production method using the novel propylene oxide. The present invention is 1,1,3-trichloro-2,3,3-trifluoropropylene oxide. The prese...  
WO/2010/104177A1
A fluoroalkanesulfinic acid ammonium salt is obtained using an organic base when a bromofluoroalkyl carboxylate ester is sulfinated using a sulfinating agent. The fluoroalkanesulfinic acid ammonium salt is oxidized, thereby obtaining a f...  
WO/2010/104178A1
An ammonium hydroxyfluoroalkanesulfinate is obtained by using an organic base while sulfinating a bromofluoroalcohol with a sulfinating agent. An ammonium hydroxyfluoroalkanesulfonate is obtained by oxidizing said ammonium hydroxyfluoroa...  
WO/2010/101204A1
A binaphthyldisulfonic acid compound represented by formula (1a) or (1b). (In the formulae, R1 is a hydrogen atom, an alkyl, or a metal ion (e.g., Li, Na, K, Mg, or Ca); R2 is a halogen atom, a heavy hydrogen atom, a trialkylsilyl, dihyd...  
WO/2010/099532A2
A method for the purification of 5-sulfoisophthalic acid wherein via the application of an acetic acid wash while said crude cake of 5-sulfoisophthalic acid is filtered.  
WO/2010/094554A1
The invention relates to an improved method for releasing an organic acid, preferably a carbon, sulfone or phosphone acid, particularly an alpha or beta hydroxycarbon acid, from the ammonia salt thereof by releasing and removing ammoniac...  
WO/2010/094630A1
The invention relates to a method for converting ammonium salts of organic acids into the respective free organic acids, wherein an aqueous solution of the ammonium salt is brought into contact with an organic extraction agent, and the s...  

Matches 701 - 750 out of 12,863